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The NADPH-oxidase of phagocytic cells is a multicomponent enzyme that generates superoxide. It
comprises a membrane ﬂavocytochrome b558 and four cytosolic proteins; p67
phox, p47phox, p40phox
and Rac. The NADPH-binding site of this complex was shown to be located on the ﬂavocytochrome
b558. However, a number of studies have suggested the presence of another site on the p67phox sub-
unit which is the key activating component. Using several approaches like tryptophan quenching
ﬂuorescence measurement, inhibition by 20,30-dialdehyde NADPH, and free/bound NADPH concen-
tration measurements, we demonstrate that no NADPH binds on p67phox, thus deﬁnitively solving
the controversy on the number and location of the NADPH-binding sites on this complex.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Human neutrophils play an essential role in the inﬂammatory
response to kill invading pathogens. Upon stimulation, neutrophils
exhibit a burst of cyanide-insensitive oxygen consumption accom-
panied by a NADPH–dependent production of superoxide anions
(O2), precursors of toxic reactive oxygen metabolites. O2 pro-
duction is catalysed by a membrane-bound electron transfer com-
plex named NADPH-oxidase (for review see [1,2]). Dysfunction of
the phagocyte NADPH-oxidase leads to severe human pathologies
like the chronic granulomatous disease (CGD).
The NADPH-oxidase is a highly regulated enzyme complex, dor-
mant in resting cells and active upon cell stimulation. The activa-
tion occurs via the phosphorylation of cytosolic regulatory
components p47phox, p67phox, p40phox and their translocation to
the transmembrane heterodimer, the ﬂavocytochrome b558
(Cytb558) in the presence of the small G protein Rac1/2. The Cytb558
is composed of two subunits, p22phox and gp91phox. The cytosolic
cofactors p47phox, p67phox are absolutely required for the enzy-
matic activity in vivo [1,3]. In vitro, the, so-called ‘‘cell-free sys-
tem”, comprised of p67phox, p47phox, Rac in its GTP bound formchemical Societies. Published by E
se; GST, glutathione-S-trans-
himie-Physique, UMR 8000-
e. Fax: +33 1 69156188.
n).and the Cytb558, is able to produce O2 upon addition of NADPH
(for review see [4]). In vitro, p47phox can be omitted if the concen-
tration of p67phox is raised up to several micromolar [5]. The
canonical view is that the NADPH-oxidase catalyses hydride trans-
fer from NADPH to FAD and successive electron transfers from FAD
to the catalytic centre (two hemes). The NADPH-binding site was
ﬁrst proposed to be located on another component than Cytb558,
hypothesis based on studies of fractions isolated from X-linked-
CGD patient’s neutrophils (lacking the gp91phox subunit). In these
fractions, NADPH-binding proteins were detected and the oxidase
activation property (i.e. O2 production) was inhibited by covalent
binding of NADPH analogs (NADPH-dialdehyde) [6]. In addition, it
was found that the oxidase cytosolic subunits bound to a 20,50-ADP
(a NADPH analog) agarose gel and could be eluted with ATP, GTP
and NADPH solutions [7]. Curiously, after labelling of the neutro-
phil fractions with radioactive nucleotides, the radioactivity was
found on various size proteins ranging from 32 to 66 kDa [6,8–10].
In the early 90s, the publication of the ﬁrst hint of the presence
of the catalytic NADPH (and FAD) binding site on the Cytb558
strongly suggesting that the C-terminus of gp91phox is a member
of the FNR family of reductase [11] clearly weakened the previous
hypothesis. This proposal was strengthened by labelling studies
from other groups showing a predominant labelling by a radioac-
tive NADPH analog on a glycosylated membrane-bound protein
of about 80–100 kDa [12,13] and by functional studies [14] show-
ing that NADPH dependent O2 production can be elicited in a cell-
free system containing Cytb558 in the total absence of cytosoliclsevier B.V. All rights reserved.
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p67phox gave controversial results. Using radioactive NADPH-dial-
dehyde for protein labelling and tryptophan ﬂuorescence quench-
ing measurements, it was proposed that the recombinant p67phox
protein contains a NADPH-binding site essential for enzyme activ-
ity, with a Kd close to 7 lM [15].
Altogether, these results maintain a doubt on the presence of
multiple NADPH-binding site in the oxidase complex, as under-
lined in several recent reviews [2,16,17]. An assessment of the
binding site on p67phox subunit is essential since it would be the
primary catalytic event within the enzyme, all other steps depend-
ing on substrate binding. The location of the nucleotide binding
site is reanalysed here on bovine and human p67phox recombinant
proteins in order to eliminate a possible species peculiarity and
with different approaches to allow the detection of a large range
of Kd value from 107 to 104 M.Fig. 1. SDS–PAGE electrophoresis of recombinant puriﬁed cytosolic p67phox and
GST-cleaved bovine GST-His-p67phox. (A) Each lane was loaded with 0.5–1.5 lg of
human His-p67phox (lane 1), human GST-p67phox (lane 2) and bovine GST-His-
p67phox (lane 3), molecular weight marker (dual-color, Biorad). (B) Undigested and
Factor-Xa digested bovine GST–His-p67phox (a: GST-tagged p67phox, b: p67phox and
c: GST-tag) and the molecular weight marker (Ozyme).2. Materials and methods
2.1. Materials
All the chemicals were obtained from Sigma–Aldrich; the Q-Se-
pharose Fast-Flow (FF), DEAE Sepharose-FF, SP-Sepharose-HP, Glu-
tathione-Sepharose-4B gels were from GE-Healthcare-Bioscience;
the His-Select Nickel Afﬁnity gel was from Sigma–Aldrich.
2.2. Recombinant protein productions and puriﬁcations
All the constructs used to produce the recombinant proteins
from the NADPH-oxidase are listed in Table S1 (Supplementary
data). Except the His-p67phox protein which was expressed in Esch-
erichia coli BL21(DE3)pLysS and induced only 6 h (30 C), all recom-
binant proteins were induced in BL21(DE3) overnight at 30 C. The
glutathione-S-transferase (GST)-tagged proteins (p67phox and
Rac1) were puriﬁed on Q-Sepharose-FF chromatography followed
by a Glutathione-Sepharose-4B afﬁnity column (elution with
50 mM Tris, 10 mM reduced glutathione, pH 8.0). The His-p67phox
was puriﬁed as above except that it was puriﬁed on a Nickel Afﬁn-
ity gel (elution with 150 mM imidazole). The His-p47phox was puri-
ﬁed through the SP-Sepharose chromatography and puriﬁed
further through a Nickel Afﬁnity gel.
The fusion-tags could be removed by the use of either thrombin
or Factor-Xa. Since the human and bovine p67phox proteins have an
additional cleavage site for these endoproteases, only the bovine
p67phox was subjected to limited digestion with protease Factor-
Xa (2 h at room temperature; 40 units of protease/mg of protein).
Protein concentrations were estimated using the Bicinchoninic
acid protein assay with BSA as standard. All isolated proteins were
subjected to 10% BisTris-NuPAGE SDS gels (Invitrogen), stained
with Coomassie Brilliant Blue (Fig. 1).
The intact nicotinamide nucleotide transhydrogenase and its
NADH-binding domain were puriﬁed as described in [18,19].
2.3. Puriﬁcation of membrane fraction from neutrophils (MF)
The membrane fraction was obtained after bovine neutrophils
puriﬁcation from blood as described in [20]. The yield was between
5 and 20 mg of membrane protein from 10 l of blood.
2.4. Tryptophan ﬂuorescence spectroscopy measurement
The tryptophan ﬂuorescence signals of bovine and human
p67phox were recorded in a 1  1 cm quartz cuvette on a Spex-Flu-
orolog1681 spectroﬂuorimeter at 25 C with an excitation and
emission wavelengths of 280 nm and 340 nm, respectively. Thetitrations were achieved by successive additions of 5 ll aliquots
of 3 mM NADPH (or NADH when indicated). A titration in identical
conditions was performed on a bovine serum albumin (BSA) sam-
ple (0.5 lM), a well-known non-NADPH-binding protein. This was
used to correct the ﬂuorescence signals from inner ﬁltering effect
[21] and dilution. To validate this method, negative and positive
controls were performed with tryptophanyl solution (8 lM) ti-
trated with NADPH and NADH-binding domain of transhydrogen-
ase (2.5 lM) with NADH, respectively. Indeed, transhydrogenase
has a Kd value for NADH (20 lM) in the same range as the one ex-
pected for the NADPH-oxidase complex [18].
2.5. Estimation of Kd by unbound and bound NADPH concentration
measurements
Four milligrams of p67phox were mixed with 2 ml of Glutathi-
one-Sepharose gel for 1 h. The gel was washed twice brieﬂy by cen-
trifugation (at 10 000 rpm) with PBS buffer to remove the unbound
proteins and then distributed in four tubes. In each tube, NADPH
was added to ﬁnal concentrations of 0 lM, 36 lM, 71 lM,
135 lM (in 0.5 ml of PBS). After 10 min incubation, the tubes were
centrifuged as previously. At this stage, the protein (15–20 lM) is
located at the bottom of the tube bound onto the gel and the free
NADPH concentration can be determined from an aliquot taken on
top of the tube. The NADPH ﬂuorescence of the diluted supernatant
(v:v 1:20) was recorded (kex = 340 nm, kem = 460 nm). Control
experiments, in the absence of proteins, were performed in paral-
lel. The levels of ﬂuorescence in the absence of NADPH as well as
the concentration of the bound protein were checked. A positive
control, showing that dinucleotides can bind to gel-trapped
proteins was realised with a His-tagged nicotinamide nucleotide
transhydrogenase bound on Nickel resin. We found that all the
binding sites were occupied at the NADPH concentrations used in
these experiments, which is in agreement with a Kd for NADPH
of 1 lM.
It should be noted that some puriﬁed protein preparations dis-
played an intrinsic NADPH oxidation activity without addition of
any oxidant. When this reaction was observed, it occurred extre-
mely slowly. However, it could cause artefacts in the estimation
of free NADPH concentration essentially because of the high level
of protein concentration used (15–20 lM). We evaluated this
undesirable NADPH oxidation by measuring spectrophotometri-
cally the NADPH absorption decrease at 340 nm for several hours
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ml PBS) with NADPH (60 lM) for each protein preparation. The
preparations presenting this activity were systematically discarded
for the binding experiments described in this report.
2.6. Preparation of NADPH-dialdehyde and protein binding procedure
The reduction of NADP+-dialdehyde was obtained as described
in [22] with some modiﬁcations. One millimolar of the NADP+ ana-
log was incubated with 2 mM isocitrate and 2 units of NADP-isoci-
trate dehydrogenase for 3 h in Tris buffer (50 mM Tris, 4 mM
MgCl2, pH 8.0) at room temperature. The sample was then loaded
on a 5 ml DEAE-Sepharose column and the NADPH-dialdehyde was
eluted with a 0–1 M NaCl gradient of 50 ml in the same buffer. The
purity and the concentration of the NADPH-dialdehyde was deter-
mined by measuring its absorbance at 340 nm and 260 nm
(e = 6.22 cm1 mM1 and 15.5 cm1 mM1, respectively [22]). The
covalent binding of the analog to p67phox or to the membrane frac-
tion was performed by mixing the protein solution (0.2–0.6 mg/
ml) with NADPH-dialdehyde (30, 73 and 110 lM), in the presence
of NaCNBH3 (500 lM). The mixture was incubated for 20 h at 5 C.
The samples were then used for NADPH-oxidase activity measure-
ments. As control, the same protocol was used in the absence of
NADPH-dialdehyde and in the presence of NADPH-dialdehyde
and NADPH (2 mM).Table 1
Estimation of Vmax and Km of NADPH for O2 production catalysed by the NADPH-
oxidase complex reconstituted either with bovine or human p67phox. Prior to NADPH
and cytochrome c addition, MF (18 lg), p67phox (15 lg), p47phox (16 lg), RacQ61L
(8 lg) and arachidonate (40 lg) are incubated 5 min in 1 mL PBS buffer and 10 mM
MgSO4.
Vmax
(lmol O2/min/mg membrane prot)
Km (lM)
Bovine GST–His-p67phox 0.34 ± 0.02 54 ± 9
Human GST-p67phox 0.42 ± 0.04 62 ± 15
Human His-p67phox 0.35 ± 0.02 31 ± 8
Fig. 2. The relative quenching of tryptophan ﬂuorescence by NADPH (A) human p67ph
p67phox (0.15 mg), tryptophan (8 lM) and NADH-binding domain of transhydrogenase (0
to the tryptophan ﬂuorescence level before the addition of NAD(P)H and corrected of the
three different p67phox preparations.2.7. Cell-free NADPH-oxidase activity assays
The O2 production initiated by the addition of NADPH was
measured at 550 nm as the rate of superoxide dismutase-inhibited
cytochrome c reduction (e = 21 mM1 cm1 [23]), according to [24]
and as described in the legend. Michaelis-Menten constant (Km)
and Vmax were determined from a titration of the activity as a func-
tion of NADPH concentration (5–300 lM).
3. Results
3.1. Comparison of NADPH-oxidase activities between the bovine and
the human recombinant p67phox
The sequence comparison of the bovine and human p67phox
shows a very high similarity (88% of identity) [25]. We measured
the rate of superoxide anion production (Vmax) in cross-species
complex to estimate the relevance of the speciﬁc interactions of
cytosolic subunits (bovine or human) with bovine membrane frac-
tions (Table 1). No signiﬁcant difference in the Vmax values was ob-
served in cell-free assays containing either the human or the
bovine recombinant p67phox protein, whatever the tag present at
the N-terminus of the recombinant protein. The obtained Vmax
and Km values are in good agreement with the literature (25–
50 lM) [8,15,26]. Our results suggest that the human GST-p67phox
leads to a NADPH-oxidase complex as efﬁcient as the one obtained
in the presence of the bovine GST–His-p67phox protein and that no
species dependent interactions are essential to build an efﬁcient
NADPH-oxidase complex. In addition, these results indicate that
neither the GST fusion protein nor the His-tag in N-terminus of
cytosolic proteins alter superoxide production, binding of NADPH
to the complex or protein interactions for correct assembly.
3.2. NADPH-binding studies on p67phox recombinant proteins
In the absorption and ﬂuorescence spectra of protein prepara-
tions, no peak characteristic to NADPH have been detected (data
not shown). So, there is no tightly bound NADPH to p67phox withox (0.13 mg), bovine p67phox or digested bovine p67phox (0.16 mg) and (B) bovine
.3 mg) (all sample diluted in PBS buffer, ﬁnal volume 3 mL). The data are normalized
inner ﬁltering effects using the BSA titrations. Same titrations (A) were obtained for
Fig. 4. Effect of NADPH-dialdehyde treatment of p67phox and MF on the O2
production rate. For a given protein, NADPH-oxidase activity is given as the
percentage of the activity obtained in the presence vs. absence of NADPH-
dialdehyde. The data is the average of three independent measurements (standard
deviation less than 10%). The rate of O2 production with the untreated proteins
was consistently around 0.3 lmol O2/min/mg membrane protein.
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determine higher NADPH dissociation constant values, two meth-
ods have been chosen. First, we followed the quenching of the
endogenous tryptophan ﬂuorescence at 340 nm by Förster reso-
nant energy transfer (FRET) to bound NADPH [15] upon excitation
at 280 nm (Fig. 2). For either bovine or human p67phox, the ﬂuores-
cence intensity does not vary upon addition of NADPH (Fig. 2A). For
the bovine p67phox, similar titrations were also observed after
digestion of the fusion domain by Factor-Xa (Fig. 2A). As positive
control, the NADH-binding domain of nicotinamide nucleotide
transhydrogenase displays a signiﬁcant tryptophan ﬂuorescence
quenching by NADH titration (Fig. 2B). By this method, the Kd value
of this protein was estimated to be 20 lM in agreement with the
literature [18]. In summary, all these titrations show that no
NADPH binding was detected on p67phox whenever the GST-tag
is present or not.
The second approach consisted in mixing NADPH with p67phox
trapped on afﬁnity gel before measuring the free NADPH concen-
tration remaining in solution. The results, presented Fig. 3, indicate
that the concentration of free NADPH was the same with and with-
out proteins whatever the NADPH concentration. Similar results
were obtained with human p67phox preparations (data not shown).
This experiment reinforces the conclusion drawn from the titra-
tions of tryptophan ﬂuorescence quenching by NADPH.
3.3. Binding of NADPH-dialdehyde on p67phox and on the membrane
fraction of neutrophils
The two methods presented above are not sensitive enough to
measure higher dissociation constant values (>100 lM). In order
to probe this range of Kd, an analog of NADPH, NADPH-dialdehyde,
associated with sodium cyanoborohydride was used. This analog
irreversibly binds to the recognition site of NADPH by a covalent
reaction and therefore should inhibit the NADPH-oxidase activity.
As shown in Fig. 4, no inhibition of superoxide production was
found when human or bovine p67phox were previously treated with
the inhibitor. In contrast, when the membrane fraction was treated
with increased inhibitor concentrations, the activities decrease by
30–90%. These results suggest that the NADPH-dialdehyde wasFig. 3. Binding measurements of NADPH on bovine p67phox. The proteins bound to
Glutathione-Sepharose were incubated with various concentrations of NADPH (36,
71 and 135 lM). After centrifugation, the free NADPH concentration was estimated
from the supernatant by ﬂuorescence measurements. Experiments without pro-
teins were realised in parallel as negative controls. As guidance, the theoretical level
of ﬂuorescence expected for a Kd value of 50 lM and a concentration of protein of
20 lM is indicated as white bars.able to react with a catalytic binding site on the membrane fraction
while not on p67phox. The NADPH speciﬁcity of this reaction was
assessed by performing the experiment in the presence of 2 mM
NADPH. In that case, no inhibition of activity was observed except
when a 110 lM inhibitor concentration was used, with 60%
activity remaining. This is in good agreement with the degree of
inhibition usually found with these concentrations of nucleotide
[22,27].
These results clearly demonstrate that NADPH binds to the
membrane fraction containing Cytb558 but not to the p67phox
protein.
4. Discussion
As mentioned earlier, NADPH is the electron donor for the one
electron reduction of molecular oxygen to superoxide anion by
the NADPH-oxidase, thus a NADPH-binding site must be present
in the catalytic core. Over the years, the NADPH-binding site has
been identiﬁed on several candidates, some of them in the cyto-
solic fraction [8,28] and more speciﬁcally on p67phox [15]. In paral-
lel, several evidences have shown that the Cytb558 was able to
functionally bind FAD and NADPH. Therefore, two hypotheses have
been formulated, either p67phox participates directly in electron
transfer between NADPH and FAD [29], or there would be a site
on p67phox, additional to the one on gp91phox, with an unknown
regulatory function [15]. This site would be located in the N-termi-
nal part of p67phox (1–210 amino acids), critical for oxidase activity
[15]. For further functional studies, especially for a detailed analy-
sis of the electron transfer between the redox prosthetic groups
within gp91phox, it was crucial to ascertain the number and the
location of the NADPH-binding site(s). Thus, we carried out exper-
iments that cover a large range of Kd values, from 107 to 104 M
whose reliability and reproducibility of the results have been im-
proved with the systematic use of recombinant cytosolic proteins.
Indeed, it should be noted that most of the previous studies were
carried out on non-puriﬁed cytosolic fractions of neutrophils,
which are likely to contain a number of NADPH-binding proteins
that could be responsible for the discrepancies observed. With all
these cautions, the experiments depicted in this work lead to the
conclusion that NADPH has no speciﬁc binding site on either bo-
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terminus of gp91phox could be modelized with a nucleotide binding
motif [30], whereas the available crystallographic 3D structures of
the N-terminus of p67phox do not show such a motif [31].
During our systematic analysis of the binding properties of
p67phox, several constructs have been used with either a GST-tag
or a His-tag or both. It should be noted that the lack of alteration
of NADPH-oxidase activity with a tag as large as GST (26 kDa) is
promising for functional studies with other tags like ﬂuorescent
protein homologues of the Green Fluorescent Protein (GFP,
23 kDa).
In conclusion, the role of p67phox is not to bring NADPH to the
complex in order to initiate electron transfer. However, this does
not exclude a function in the control of NADPH-binding afﬁnity
through conformational changes induced in the Cytb558 structure
through a direct interaction between the two proteins and/or in
the regulation of the electron ﬂow and more precisely of ﬂavin
reduction by NADPH.
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